• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis. Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020

tetano

Editor, Senior Moderator
Clin Infect Dis. 2020 Apr 11. pii: ciaa424. doi: 10.1093/cid/ciaa424. [Epub ahead of print]
Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020.


Danis K[SUP]1[/SUP], Epaulard O[SUP]2,[/SUP][SUP]3,[/SUP][SUP]4[/SUP], B?net T[SUP]5[/SUP], Gaymard A[SUP]6[/SUP], Campoy S[SUP]7[/SUP], Bothelo-Nevers E[SUP]8,[/SUP][SUP]9[/SUP], Bouscambert-Duchamp M[SUP]6[/SUP], Spaccaferri G[SUP]5[/SUP], Ader F[SUP]10[/SUP], Mailles A[SUP]1[/SUP], Boudalaa Z[SUP]7[/SUP], Tolsma V[SUP]11[/SUP], Berra J[SUP]7[/SUP], Vaux S[SUP]1[/SUP], Forestier E[SUP]12[/SUP], Landelle C[SUP]13,[/SUP][SUP]14[/SUP], Fougere E[SUP]5[/SUP], Thabuis A[SUP]5[/SUP], Berthelot P[SUP]8,[/SUP][SUP]9[/SUP], Veil R[SUP]15[/SUP], Levy-Bruhl D[SUP]1[/SUP], Chidiac C[SUP]10,[/SUP][SUP]16[/SUP], Lina B[SUP]6[/SUP], Coignard B[SUP]1[/SUP], Saura C[SUP]5[/SUP]; Investigation Team.

Collaborators (64)




Author information




Abstract

BACKGROUND:

On 07/02/2020, French Health authorities were informed of a confirmed case of SARS-CoV-2 coronavirus in an Englishman infected in Singapore who had recently stayed in a chalet in the French Alps. We conducted an investigation to identify secondary cases and interrupt transmission.
METHODS:

We defined as a confirmed case a person linked to the chalet with a positive RT-PCR sample for SARS-CoV-2.
RESULTS:

The index case stayed 4 days in the chalet with 10 English tourists and a family of 5 French residents; SARS-CoV-2 was detected in 5 individuals in France, 6 in England (including the index case), and 1 in Spain (overall attack rate in the chalet: 75%). One pediatric case, with picornavirus and influenza A coinfection, visited 3 different schools while symptomatic. One case was asymptomatic, with similar viral load as that of a symptomatic case. Seven days after the first cases were diagnosed, one tertiary case was detected in a symptomatic patient with a positive endotracheal aspirate; all previous and concurrent nasopharyngeal specimens were negative. Additionally, 172 contacts were monitored, including 73 tested negative for SARS-CoV-2.
CONCLUSIONS:

The occurrence in this cluster of one asymptomatic case with similar viral load as a symptomatic patient, suggests transmission potential of asymptomatic individuals. The fact that an infected child did not transmit the disease despite close interactions within schools suggests potential different transmission dynamics in children. Finally, the dissociation between upper and lower respiratory tract results underscores the need for close monitoring of the clinical evolution of suspect Covid-19 cases.
? The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.



KEYWORDS:

Covid-19; SARS-CoV-2; cluster; coronavirus; infection


PMID:32277759DOI:10.1093/cid/ciaa424
 
Back
Top Bottom